These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 37269482
21. Resolvin D3 improves the impairment of insulin signaling in skeletal muscle and nonalcoholic fatty liver disease through AMPK/autophagy-associated attenuation of ER stress. Oh H, Cho W, Abd El-Aty AM, Bayram C, Jeong JH, Jung TW. Biochem Pharmacol; 2022 Sep; 203():115203. PubMed ID: 35948170 [Abstract] [Full Text] [Related]
22. FNDC5 Alleviates Hepatosteatosis by Restoring AMPK/mTOR-Mediated Autophagy, Fatty Acid Oxidation, and Lipogenesis in Mice. Liu TY, Xiong XQ, Ren XS, Zhao MX, Shi CX, Wang JJ, Zhou YB, Zhang F, Han Y, Gao XY, Chen Q, Li YH, Kang YM, Zhu GQ. Diabetes; 2016 Nov; 65(11):3262-3275. PubMed ID: 27504012 [Abstract] [Full Text] [Related]
23. ApoE deficiency promotes non-alcoholic fatty liver disease in mice via impeding AMPK/mTOR mediated autophagy. Lu W, Mei J, Yang J, Wu Z, Liu J, Miao P, Chen Y, Wen Z, Zhao Z, Kong H, Wu C, Yang Y, Chen M. Life Sci; 2020 Jul 01; 252():117601. PubMed ID: 32304762 [Abstract] [Full Text] [Related]
24. Barley sprout extracts reduce hepatic lipid accumulation in ethanol-fed mice by activating hepatic AMP-activated protein kinase. Kim YJ, Hwang SH, Jia Y, Seo WD, Lee SJ. Food Res Int; 2017 Nov 01; 101():209-217. PubMed ID: 28941686 [Abstract] [Full Text] [Related]
25. Asperuloside alleviates lipid accumulation and inflammation in HFD-induced NAFLD via AMPK signaling pathway and NLRP3 inflammasome. Shen Q, Chen Y, Shi J, Pei C, Chen S, Huang S, Li W, Shi X, Liang J, Hou S. Eur J Pharmacol; 2023 Mar 05; 942():175504. PubMed ID: 36641101 [Abstract] [Full Text] [Related]
26. Inhibition of ghrelin o-acyltransferase attenuated lipotoxicity by inducing autophagy via AMPK-mTOR pathway. Zhang S, Mao Y, Fan X. Drug Des Devel Ther; 2018 Mar 05; 12():873-885. PubMed ID: 29713145 [Abstract] [Full Text] [Related]
27. Ginsenoside Rg5 Activates the LKB1/AMPK/mTOR Signaling Pathway and Modifies the Gut Microbiota to Alleviate Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet. Shi Y, Chen J, Qu D, Sun Q, Yu Y, Zhang H, Liu Z, Sha J, Sun Y. Nutrients; 2024 Mar 15; 16(6):. PubMed ID: 38542753 [Abstract] [Full Text] [Related]
28. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1/AMPK and NF-κB signaling pathways. Li CX, Gao JG, Wan XY, Chen Y, Xu CF, Feng ZM, Zeng H, Lin YM, Ma H, Xu P, Yu CH, Li YM. World J Gastroenterol; 2019 Sep 14; 25(34):5120-5133. PubMed ID: 31558861 [Abstract] [Full Text] [Related]
29. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway. Zhu X, Bian H, Wang L, Sun X, Xu X, Yan H, Xia M, Chang X, Lu Y, Li Y, Xia P, Li X, Gao X. Free Radic Biol Med; 2019 Sep 14; 141():192-204. PubMed ID: 31226399 [Abstract] [Full Text] [Related]
30. LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway. Chen XY, Cai CZ, Yu ML, Feng ZM, Zhang YW, Liu PH, Zeng H, Yu CH. World J Gastroenterol; 2019 Dec 07; 25(45):6607-6618. PubMed ID: 31832001 [Abstract] [Full Text] [Related]
31. Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway. Li Q, Tan JX, He Y, Bai F, Li SW, Hou YW, Ji LS, Gao YT, Zhang X, Zhou ZH, Yu Z, Fang M, Gao YQ, Li M. Int J Biol Sci; 2022 Dec 07; 18(4):1594-1611. PubMed ID: 35280674 [Abstract] [Full Text] [Related]
32. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice. Liou CJ, Wei CH, Chen YL, Cheng CY, Wang CL, Huang WC. Cell Physiol Biochem; 2018 Dec 07; 49(5):1870-1884. PubMed ID: 30235452 [Abstract] [Full Text] [Related]
33. Activation of AMPK by triptolide alleviates nonalcoholic fatty liver disease by improving hepatic lipid metabolism, inflammation and fibrosis. Huang R, Guo F, Li Y, Liang Y, Li G, Fu P, Ma L. Phytomedicine; 2021 Nov 07; 92():153739. PubMed ID: 34592488 [Abstract] [Full Text] [Related]
34. AMPK/mTOR pathway significance in healthy liver and non-alcoholic fatty liver disease and its progression. Marcondes-de-Castro IA, Reis-Barbosa PH, Marinho TS, Aguila MB, Mandarim-de-Lacerda CA. J Gastroenterol Hepatol; 2023 Nov 07; 38(11):1868-1876. PubMed ID: 37438882 [Abstract] [Full Text] [Related]
35. Sodium Butyrate Supplementation Inhibits Hepatic Steatosis by Stimulating Liver Kinase B1 and Insulin-Induced Gene. Zhao ZH, Wang ZX, Zhou D, Han Y, Ma F, Hu Z, Xin FZ, Liu XL, Ren TY, Zhang F, Xue Y, Cui A, Liu Z, Bai J, Liu Y, Cai G, Su W, Dai X, Shen F, Pan Q, Li Y, Fan JG. Cell Mol Gastroenterol Hepatol; 2021 Nov 07; 12(3):857-871. PubMed ID: 33989817 [Abstract] [Full Text] [Related]
36. Ginsenoside Rb2 Alleviates Hepatic Lipid Accumulation by Restoring Autophagy via Induction of Sirt1 and Activation of AMPK. Huang Q, Wang T, Yang L, Wang HY. Int J Mol Sci; 2017 May 19; 18(5):. PubMed ID: 28534819 [Abstract] [Full Text] [Related]
37. Salvia plebeia R. Br. Water Extract Ameliorates Hepatic Steatosis in a Non-Alcoholic Fatty Liver Disease Model by Regulating the AMPK Pathway. Bae S, Lee YH, Lee J, Park J, Jun W. Nutrients; 2022 Dec 18; 14(24):. PubMed ID: 36558538 [Abstract] [Full Text] [Related]
38. Wulingsan Alleviates MAFLD by Activating Autophagy via Regulating the AMPK/mTOR/ULK1 Signaling Pathway. Biao Y, Li D, Zhang Y, Gao J, Xiao Y, Yu Z, Li L. Can J Gastroenterol Hepatol; 2024 Dec 18; 2024():9777866. PubMed ID: 39035827 [Abstract] [Full Text] [Related]
39. LRG ameliorates steatohepatitis by activating the AMPK/mTOR/SREBP1 signaling pathway in C57BL/6J mice fed a high‑fat diet. Hao T, Chen H, Wu S, Tian H. Mol Med Rep; 2019 Jul 18; 20(1):701-708. PubMed ID: 31180545 [Abstract] [Full Text] [Related]